Complications | Total (N = 429) | EIBL< 100 mL (N = 296) | EIBL≥100 mL (N = 133) | P-value |
---|---|---|---|---|
Overall morbidity | ||||
 Any cardiopulmonary complication | 80 (18.6%) | 40 (13.5%) | 40 (30.1%) | < 0.001 |
 Pulmonary complications | 74 (17.2%) | 35 (11.8%) | 39 (29.3%) | < 0.001 |
 Cardiovascular complications | 12 (2.8%) | 5 (1.7%) | 7 (5.3%) | 0.038 |
Individual cardiopulmonary complications | ||||
 Pneumonia | 49 (11.4%) | 22 (7.4%) | 27 (20.3%) | < 0.001 |
 Atelectasis | 25 (5.8%) | 8 (2.7%) | 17 (12.8%) | < 0.001 |
 Pleural effusion requiring chest tube drainage | 9 (2.1%) | 4 (1.4%) | 5 (3.8%) | 0.21 |
 Pulmonary artery embolism | 3 (0.7%) | 1 (0.3%) | 2 (1.5%) | 0.23 |
 Hemoptysis requiring pharmacological intervention | 2 (0.5%) | 2 (0.7%) | 0 (0.0%) | 1.0 |
 Acute respiratory distress syndrome | 1 (0.2%) | 1 (0.3%) | 0 (0.0%) | 1.0 |
 Atrial fibrillation | 4 (0.9%) | 2 (0.7%) | 2 (1.5%) | 0.59 |
 Sinus irregularity requiring pharmacological intervention | 5 (1.2%) | 2 (0.7%) | 3 (2.3%) | 0.18 |
 Ventricular fibrillation | 2 (0.5%) | 0 (0.0%) | 2 (1.5%) | 0.096 |